- Report
- September 2022
- 225 Pages
Global
From €7212EUR$7,500USD£6,187GBP
Privigen is a brand of intravenous immunoglobulin (IVIG) used to treat primary immunodeficiency diseases and other conditions. It is used to treat a variety of conditions, including leukemia, a type of cancer of the blood and bone marrow. Privigen is a concentrated solution of antibodies derived from healthy donors, which helps to boost the patient's immune system and fight off infection. It is administered intravenously, usually over a period of several hours.
Privigen is a relatively new drug in the market, but it has been gaining traction in recent years due to its effectiveness in treating leukemia. It is often used in combination with other treatments, such as chemotherapy, to help reduce the risk of relapse.
Some companies in the Privigen market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more